8 completed, 4 recruiting, 3 unknown, 2 active not recruiting. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 8, Recruiting 4, Unknown 3, Active not recruiting 2, Not yet recruiting 2, Terminated 1, Withdrawn 1 |
Follow Bariatric Surgery: new trials by email Literature Review of Bariatric Surgery trials Research Report on Bariatric Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Swap Anesthetic Versus Continuous Desflurane in Adults Undergoing Bariatric Surgery Desflurane, Sevoflurane-Desflurane - Obesity, Bariatric Surgery | Phase 4 | Not yet recruiting | Clínica Dávila | 82 | 2026-08-03 | 2026-08-05 |
| The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression Esketamine, Dexmedetomidine - Depressed, Bariatric Surgery | Phase 4 | Active not recruiting | The First Hospital of Jilin University | 40 | 2026-05-01 | 2026-05-08 |
| Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH) Glucagon for Injection (Fresenius Kabi USA), [6,6-2H2] glucose, [13C9, 15N1]-glucagon - Hypoglycemia, Hypoglycemia, Reactive | Phase 4 | Recruiting | Joslin Diabetes Center | 40 | 2026-01-27 | 2026-09-14 |
| Opioid-Free Versus Opioid-Based Anesthesia in Bariatric Intraoperative rescue analgesia, Intraoperative rescue analgesia: - Obesity, Bariatric Surgery | Phase 4 | Not yet recruiting | Siirt Training and Research Hospital | 50 | 2025-08-20 | 2025-08-06 |
| Simethicone as Part of ERAS in Bariatric Surgery Patients Simethicone 80 MG, Placebo - Simethicone, Bariatric Surgery | Phase 4 | Recruiting | Madigan Army Medical Center | 260 | 2025-04-08 | 2025-06-15 |
| 2024 Tirzepatide-Bariatric Surgery tirzepatide, Standard of Care - Obesity and Obesity-related Medical Conditions, Bariatric Surgery | Phase 4 | Recruiting | Marlene Starr | 50 | 2025-03-27 | 2026-05-14 |
| Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia Glucagon for Injection (Fresenius Kabi USA) - Hypoglycemia, Hypoglycemia, Reactive | Phase 4 | Active not recruiting | Joslin Diabetes Center | 28 | 2024-11-26 | 2026-02-06 |
| Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery Liraglutide injection, Diet and exercise guidelines - Obesity, Weight Loss | Phase 4 | Completed | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 100 | 2023-09-01 | 2026-01-28 |
| Opioid-sparing Versus Sevoflurane Anesthesia on Early Postoperative Hypoventilation in Laparoscopic Bariatric Surgery Opioid-sparing based anesthesia, Sevoflurane-based anesthesia - Anesthesia, Hypoventilation | Phase 4 | Unknown | Tanta University | 72 | 2023-08-10 | 2023-07-27 |
| Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery Tranexamic Acid, Normal Saline (Placebo) - Hemorrhage, Bariatric Surgery | Phase 4 | Recruiting | Patel Hospital, Pakistan | 140 | 2023-06-12 | 2025-08-01 |
| Efficacy and Safety of Ciprofol in Laparoscopic Sleeve Gastrectomy Ciprofol, Propofol - Bariatric Surgery | Phase 4 | Completed | The Third People's Hospital of Chengdu | 212 | 2023-01-01 | 2024-08-28 |
| Dual-dose Aprepitant to Reduce Postoperative Nausea and Vomiting After Laparoscopic Bariatric Surgery. Aprepitant 80 mg, Placebo - Postoperative Nausea and Vomiting, Bariatric Surgery | Phase 4 | Terminated | Insel Gruppe AG, University Hospital Bern | 71 | 2022-03-17 | 2025-02-27 |
| Dexlansoprazole Absorption and Marginal Ulceration After Gastric Bypass dexlansoprazole serum concentration, upper endoscopy - Bariatric Surgery | Phase 4 | Withdrawn | Spital Limmattal Schlieren | 2022-01-01 | 2026-06-09 | |
| Impact of Bariatric Surgery on Pharmacokinetic Study of Simvastatin and Carvedilol Digestive biopsy, Carvedilol 25mg, Serial blood sampling for PK analysis - Obesity, Bariatric Surgery | Phase 4 | Unknown | Natalia Valadares de Moraes | 120 | 2019-06-01 | 2022-02-08 |
| Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy Botulinum toxin pyloroplasty, Normal saline pyloric injection - Bariatric Surgery, Postoperative Nausea and Vomiting | Phase 4 | Completed | Albany Medical College | 84 | 2019-01-07 | 2023-04-10 |
| Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery Phentermine, Placebo - Obesity, Morbid Obesity | Phase 4 | Completed | Hospital Juarez de Mexico | 92 | 2018-03-01 | 2020-07-29 |
| Apixaban Pharmacokinetics in Bariatric Patients (APB) Apixaban - Bariatric Surgery, Obesity | Phase 4 | Completed | Johns Hopkins University | 33 | 2017-07-19 | 2020-12-22 |
| Iron Absorption Trial Ferrous fumarate, Ferrous gluconate - Iron Absorption, Bariatric Surgery | Phase 4 | Completed | Rijnstate Hospital | 24 | 2014-08-01 | 2020-06-11 |
| Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions rocuronium - Bariatric Surgery, Laparoscopic Bariatric Surgery | Phase 4 | Unknown | Central Hospital, Nancy, France | 92 | 2014-07-01 | 2015-07-30 |
| Tissue and Plasma Pharmacokinetics of Cefazolin in Antibiotic Prophylaxis in Bariatric Surgery Cefazoline - Bariatric Surgery | Phase 4 | Completed | Nantes University Hospital | 117 | 2012-03-01 | 2017-07-19 |
Showing 20 of 21. Sign in to see all of them.
Obesity (7) · Obesity, Morbid (3) · Hypoglycemia (2) · Postoperative Nausea and Vomiting (2) · Weight Loss (2) · Agnosia (1) · Consciousness Disorders (1) · Depression (1) · Hemorrhage (1) · Hypoventilation (1) · Non-alcoholic Fatty Liver Disease (1) · Pain, Postoperative (1)
Pathological Conditions, Signs and Symptoms (14) · Signs and Symptoms (14) · Nutritional and Metabolic Diseases (11) · Body Weight (9) · Nutrition Disorders (9) · Overnutrition (9) · Overweight (9) · Pathologic Processes (4) · Neurologic Manifestations (3) · Postoperative Complications (3) · Body Weight Changes (2) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nausea (2) · Nervous System Diseases (2)
Glucagon (2) · Injections (2) · Rocuronium (2) · (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (1) · Analgesics, Opioid (1) · Aprepitant (1) · Carvedilol (1) · Cefazolin (1) · Control Groups (1) · Desflurane (1) · Dexmedetomidine (1) · Diet (1) · Esketamine (1) · Gastroscopy (1) · Genotype (1)
Joslin Diabetes Center (2) · Albany Medical College (1) · Central Hospital, Nancy, France (1) · Clínica Dávila (1) · Copenhagen University Hospital, Rigshospitalet (1) · Hospital Juarez de Mexico (1) · Insel Gruppe AG, University Hospital Bern (1) · Johns Hopkins University (1) · Madigan Army Medical Center (1) · Marlene Starr (1) · Nantes University Hospital (1) · Natalia Valadares de Moraes (1) · Patel Hospital, Pakistan (1) · Rijnstate Hospital (1) · Siirt Training and Research Hospital (1)
United States (7) · China (3) · France (2) · Chile (1) · Denmark (1) · Egypt (1) · Mexico (1) · Netherlands (1) · Pakistan (1) · Switzerland (1)
Ananda Basu, MD (1) · Barbara Nikolajczyk, PhD (1) · Brent Petty (1) · Casper Claudius, MD, PhD (1) · Christian M Beilstein, MD (1) · Christian S Meyhoff, MD, PhD (1) · Ghulam Murtaza, MBBS, FCPS, MRCS, MSc (epi) (1) · Jessica Zaman, MD (1) · Jose S dos Santos, PhD (1) · Lars S Rasmussen, MD, DMSc (1) · Marlene Starr, PhD (1)
PMID 19690247, PMID 26140855, PMID 26694209, PMID 27230645, PMID 29327182, PMID 29793587, PMID 30232617, PMID 30524741, PMID 30985536, PMID 32045513, PMID 40705792, PMID 41643256
R01DK137518 (2), 2014 (1), 2019 (1)